Literature DB >> 28469954

Osteosarcoma cell-intrinsic colony stimulating factor-1 receptor functions to promote tumor cell metastasis through JAG1 signaling.

Zhi-Qiang Wen1, Xi-Gong Li1, Yi-Jun Zhang1, Zhi-Heng Ling1, Xiang-Jin Lin1.   

Abstract

Therapeutic antibodies or inhibitors targeting CSF-1R block colony stimulating factor-1/colony stimulating factor-1 receptor (CSF-1/CSF-R) signaling, and have shown remarkable efficacy in the treatment of cancer. However, little is known about tumor cell-intrinsic CSF-1R effects. Here, we show that human osteosarcomas contain CSF-1R-expressing cancer subpopulations, and demonstrate that osteosarcoma cell-intrinsic CSF-1R promotes growth in vitro and in vivo. CSF-1R inhibition in osteosarcoma cells by RNA interference suppresses cell proliferation and tumor growth in mice. Conversely, CSF-1R overexpression enhances cell proliferation and accelerates tumor growth. CSF-1R overexpression can significantly enhance osteosarcoma cell migration, invasion, and epithelial-mesenchymal transition (EMT), whereas silencing CSF-1R inhibits these processes. Microarray analysis suggests that jagged 1 (JAG1) can function as a downstream mediator of CSF-1R. Moreover, we report a signaling pathway involving CSF-1R and JAG1 that sustains osteosarcoma cell migration and invasion. Our results identify osteosarcoma cell intrinsic functions of the CSF-1R/JAG1 axis in dissemination of osteosarcoma cells.

Entities:  

Keywords:  CSF-1R; EMT; JAG1; metastasis; osteosarcoma

Year:  2017        PMID: 28469954      PMCID: PMC5411789     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  24 in total

1.  The Role of TLR4 in M1 Macrophage-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells.

Authors:  Jun Shi; Qing Li; Meixiao Sheng; Min Zheng; Manshu Yu; Lu Zhang
Journal:  Cell Physiol Biochem       Date:  2016-12-21

2.  Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2.

Authors:  Graziana Digiacomo; Marina Ziche; Persio Dello Sbarba; Sandra Donnini; Elisabetta Rovida
Journal:  FASEB J       Date:  2015-03-10       Impact factor: 5.191

3.  Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibody.

Authors:  M B Flick; E Sapi; P L Perrotta; M G Maher; R Halaban; D Carter; B M Kacinski
Journal:  Oncogene       Date:  1997-05-29       Impact factor: 9.867

4.  Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression.

Authors:  Hisamitsu Ide; David B Seligson; Sanaz Memarzadeh; Li Xin; Steve Horvath; Purnima Dubey; Maryann B Flick; Barry M Kacinski; Aarno Palotie; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-15       Impact factor: 11.205

Review 5.  Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms.

Authors:  Barry Kascinski
Journal:  Cancer Treat Res       Date:  2002

6.  Colony stimulating factor-1 receptor signaling networks inhibit mouse macrophage inflammatory responses by induction of microRNA-21.

Authors:  Cristina I Caescu; Xingyi Guo; Lydia Tesfa; Tushar D Bhagat; Amit Verma; Deyou Zheng; E Richard Stanley
Journal:  Blood       Date:  2015-01-08       Impact factor: 22.113

7.  Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.

Authors:  Eugene P Toy; Masoud Azodi; Nancy L Folk; Christina M Zito; Caroline J Zeiss; Setsuko K Chambers
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

8.  The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor.

Authors:  Agnieszka Swierczak; Andrew D Cook; Jason C Lenzo; Christina M Restall; Judy P Doherty; Robin L Anderson; John A Hamilton
Journal:  Cancer Immunol Res       Date:  2014-04-29       Impact factor: 11.151

9.  Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.

Authors:  Carola H Ries; Michael A Cannarile; Sabine Hoves; Jörg Benz; Katharina Wartha; Valeria Runza; Flora Rey-Giraud; Leon P Pradel; Friedrich Feuerhake; Irina Klaman; Tobin Jones; Ute Jucknischke; Stefan Scheiblich; Klaus Kaluza; Ingo H Gorr; Antje Walz; Keelara Abiraj; Philippe A Cassier; Antonio Sica; Carlos Gomez-Roca; Karin E de Visser; Antoine Italiano; Christophe Le Tourneau; Jean-Pierre Delord; Hyam Levitsky; Jean-Yves Blay; Dominik Rüttinger
Journal:  Cancer Cell       Date:  2014-06-02       Impact factor: 31.743

10.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression.

Authors:  Stephanie M Pyonteck; Leila Akkari; Alberto J Schuhmacher; Robert L Bowman; Lisa Sevenich; Daniela F Quail; Oakley C Olson; Marsha L Quick; Jason T Huse; Virginia Teijeiro; Manu Setty; Christina S Leslie; Yoko Oei; Alicia Pedraza; Jianan Zhang; Cameron W Brennan; James C Sutton; Eric C Holland; Dylan Daniel; Johanna A Joyce
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

View more
  4 in total

1.  Identification of Small-Molecule Inhibitors for Osteosarcoma Targeted Therapy: Synchronizing In Silico, In Vitro, and In Vivo Analyses.

Authors:  Juan Liu; Qi Yao; Yu Peng; Zhihong Dong; Lu Tang; Xiaoyu Su; Lishuang Liu; Cheng Chen; Murugan Ramalingam; Lijia Cheng
Journal:  Front Bioeng Biotechnol       Date:  2022-06-23

2.  Sirtuin 7 plays an oncogenic role in human osteosarcoma via downregulating CDC4 expression.

Authors:  Wang Wei; Zhang Xiao Jing; Zheng Ke; Pei Yi
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

3.  The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration.

Authors:  Jiahua Li; Hui Shi; Zhanyuan Yuan; Zhiheng Wu; Haohao Li; Yuelong Liu; Ming Lu; Ming Lu
Journal:  BMC Cancer       Date:  2022-01-25       Impact factor: 4.430

4.  MiR-511 mimic transfection inhibits the proliferation, invasion of osteosarcoma cells and reduces metastatic osteosarcoma tumor burden in nude mice via targeting MAPK1.

Authors:  Junxue Wu; Chao Zhang; Lu Chen
Journal:  Cancer Biomark       Date:  2019       Impact factor: 4.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.